TrialThe European respiratory journal2014

Tumour necrosis factor receptor-75 and risk of COPD exacerbation in the azithromycin trial.

Prescott G Woodruff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.